For the Inventor, By the Inventor

Enter assignee name

Newark, CA, United States of America

Dna Twopointo Inc.

USPTO Granted Patents = 37

EPO Patents = 5

Trademarks = 8

Forward Citations = 192

Loading Chart...

Loading Chart...

20 inventors (with patents filed for the assignee):

Jeremy S Minshull (32 out of 126 patents)

Maggie Lee (17 out of 21 patents)

Sridhar Govindarajan (14 out of 39 patents)

4. Jon Edward Ness (9 out of 42 patents)

5. Claes Gustafsson (8 out of 44 patents)

6. Mark D Welch (7 out of 40 patents)

7. Elias Theodorou (5 out of 5 patents)

8. Sridhar Govindrajan (3 out of 10 patents)

9. Kate Caves (3 out of 9 patents)

10. Varsha Sitaraman (2 out of 2 patents)

11. Ferenc Boldog (2 out of 2 patents)

12. Benedikt K Vollrath (1 out of 27 patents)

13. Mark Cobbold (1 out of 16 patents)

14. Wenhua Lu (1 out of 9 patents)

15. Richard A Gross (1 out of 36 patents)

37 patents: Sort by Forward Citations

1. 12742171 - Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias (2026-09-22),

2. 12612646 - DNA vectors and elements for sustained gene expression in eukaryotic cells (2026-04-28),

3. 12590319 - Transposition of nucleic acid constructs into eukaryotic genomes with a transposase from amyelois (2026-03-31),

4. 12473335 - ORTHOGONAL IL-21 RECEPTOR/CYTOKINE SYSTEMS (2025-11-18),

5. 12419913 - Modification of CAR-T cells (2025-09-23),

6. 12404504 - Transposition of nucleic acids into eukaryotic genomes with a transposase from heliothis (2025-09-02),

7. 12351813 - Tetracycline-inducible expression system (2025-07-08),

8. 12351800 - Modifications of mammalian cells using artificial micro-RNA to alter their properties and the compositions of their products (2025-07-08),

9. 12122995 - DNA vectors, transposons and transposases for eukaryotic genome modification (2024-10-22),

10. 12054702 - DNA vectors, transposons and transposases for eukaryotic genome modification (2024-08-06),

11. 11845936 - Modifications of mammalian cells using artificial micro-RNA to alter their properties and the compositions of their products (2023-12-19),

12. 11713468 - DNA vectors and elements for sustained gene expression in eukaryotic cells (2023-08-01),

13. 11566262 - Tetracycline-inducible expression systems (2023-01-31),

14. 11401521 - Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias (2022-08-02),

15. 11396662 - Transposition of nucleic acid constructs into eukaryotic genomes with a transposase from amyelois (2022-07-26),

Dna Twopointo Inc. is a biotechnology company based in Newark, California, specializing in advanced DNA sequencing technologies. The organization focuses on developing innovative solutions that enhance genetic analysis and facilitate research in genomics. By leveraging cutting-edge methodologies, Dna Twopointo aims to support various applications in healthcare, agriculture, and environmental science, contributing to a deeper understanding of genetic information and its implications across multiple domains.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

37 Patents

#13 in Newark, CA

#2,187 in California

#9,241 in US

#18,238 in the World

Newark, CA, United States of America

Dna Twopointo Inc.

Forward Citations = 192

20 inventors:

Jeremy S Minshull (32 out of 126 patents)

Maggie Lee (17 out of 21 patents)

Sridhar Govindarajan (14 out of 39 patents)

4. Jon Edward Ness (9 out of 42 patents)

5. Claes Gustafsson (8 out of 44 patents)

Please report any incorrect information to [email protected]

Loading…